Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by sury – India, 2019-04-03 12:28 (467 d 23:41 ago) – Posting: # 20117
Views: 2,206

Hii All,

Hope all are doing well....

Recently i have received to provide the sample size based on the Pharmacodynamic endpoints.

As we use the ISCV for the estimation of sample size in general Bioequivalence studies.

Can anyone have any idea how can we provide sample size for the PD endpopints


Responses are highly appreciated.:-)

Thanks all


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
20,834 posts in 4,358 threads, 1,449 registered users;
online 24 (1 registered, 23 guests [including 12 identified bots]).
Forum time: 12:10 CEST (Europe/Vienna)

[Those] who have an excessive faith in their theories or in their
ideas are not only poorly disposed to make discoveries, but they
also make very poor observations.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5